RxDoctor Payments Data

Don Gibson, MD

Family Medicine · Mount Juliet, TNNPI 1326451246

Payments from drug & device makers

$2,210in general payments, 2019–2025

Across 138 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$672
  • Novo Nordisk$293
  • Lilly USA, LLC$271
  • Merck$255
  • AbbVie$173
  • Johnson & Johnson$124
  • plus $423 from 11 others

What the payments were for

  • Food & beverage$2,210100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,210 in reported general payments places this provider in the 70th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$23,692
Medicare patients
101
Services billed
503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin55$55,068
OzempicSemaglutide52$52,611
FarxigaDapagliflozin Propanediol52$48,216
LinzessLinaclotide47$41,995
Breztri AerosphereBudesonide/Glycopyr/Formoterol36$33,840
EliquisApixaban27$32,786
MounjaroTirzepatide21$27,243
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$19,249
Tresiba Flextouch U-200Insulin Degludec20$16,857
JanuviaSitagliptin Phosphate17$15,037
RybelsusSemaglutide13$12,201
EntrestoSacubitril/Valsartan11$9,826
TradjentaLinagliptin12$9,501
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$3,669
Albuterol Sulfate HfaAlbuterol Sulfate134$3,118

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$672$82,05688 claims
Novo NordiskOzempic, Rybelsus$293$64,81265 claims
Boehringer IngelheimJardiance, Tradjenta$33$64,56967 claims
AbbVieLinzess$173$41,99547 claims
PfizerEliquis$24$32,78627 claims
Lilly USA, LLCMounjaro$271$27,24321 claims
GSKTrelegy Ellipta$71$19,24920 claims
MerckJanuvia$255$15,03717 claims
NovartisEntresto$60$9,82611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Mount Juliet

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →